Scholarlink

Introduction <p>Pulmonary involvement is the most common extra-glandular manifestation in primary Sjögren’s syndrome (pSS), adversely affecting patient prognosis. Nonspecific interstitial pneumonia, pulmonary embolism, and pulmonary hypertension are infrequently observed in patients with Sjögren’s syndrome, thereby complicating the diagnostic process.</p> Case report <p>This case report presents a patient with a five-year history of pulmonary fibrosis, referred for worsening shortness of breath. The patient was later diagnosed with pSS, which included pulmonary involvement, pulmonary hypertension, and pulmonary thrombosis.</p> Conclusion <p>This case highlights the need to recognize pulmonary manifestations of pSS and the complexities of managing patients, especially regarding complications like pulmonary hypertension and thrombosis. Pulmonary disease treatment in pSS should be guided by the extent and progression of pulmonary involvement, utilizing glucocorticoids or other immunosuppressive drugs based on experiences from other immune-mediated diseases.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Uncommon cardiovascular and pulmonary complications prompt diagnosis of primary Sjögren's syndrome: a case report and literature review

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月16日

查看全文
  • Mohammad Hadi Tajik Jalayeri,
  • Narges Lashkarbolouk,
  • Mohaddeseh Dankoob,
  • Mahdi Mazandarani

摘要

Introduction

Pulmonary involvement is the most common extra-glandular manifestation in primary Sjögren’s syndrome (pSS), adversely affecting patient prognosis. Nonspecific interstitial pneumonia, pulmonary embolism, and pulmonary hypertension are infrequently observed in patients with Sjögren’s syndrome, thereby complicating the diagnostic process.

Case report

This case report presents a patient with a five-year history of pulmonary fibrosis, referred for worsening shortness of breath. The patient was later diagnosed with pSS, which included pulmonary involvement, pulmonary hypertension, and pulmonary thrombosis.

Conclusion

This case highlights the need to recognize pulmonary manifestations of pSS and the complexities of managing patients, especially regarding complications like pulmonary hypertension and thrombosis. Pulmonary disease treatment in pSS should be guided by the extent and progression of pulmonary involvement, utilizing glucocorticoids or other immunosuppressive drugs based on experiences from other immune-mediated diseases.